Genetic polymorphisms of CYP2C19 were found to be associated with a greater risk of HCC in Japanese cirrhotic patients with HCV infection 43, as well as a significant risk of triple‐negative breast cancer 44 and lung cancer in combination analysis with smoking in a Chinese population 45. This evidence concerns the gene CYP2C19 and hepatocellular carcinoma.